ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO and CAP Issue Guideline To Improve HER2 Testing

October 25, 2013

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

November 23, 1974

New Mammography Guidelines Cut Uses By Women Under 50 t 25%

July 29, 1977

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

Foundation For COG Is New Name Of NCCF.

October 19, 2001